Faisal Ghiath Sukhtian
CIK 1716033 · last filed 2026-05-27
Faisal Ghiath Sukhtian is a corporate insider who has filed 21 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing shows the insider bought $50.0K of OTLK on May 27, 2026. Across all open-market trades the lifetime net is +$138.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $153.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$153.2K
4
21
$138.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 125,574 | $1.22 | $153.2K | $88.7K | 10 | 2026-05-27 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 38,000 | $0.03 | $1.1K | $50.1K | 9 | 2021-12-02 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | Director | 52,904,631 | — | — | $0 | 1 | 2018-11-09 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2017-11-02 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | OTLK | Buy (P) | +122,174 | $50.0K | EDGAR |
| 2025-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-10-05 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-10-11 | OTLK | Buy (P) | +30,000 | $38.7K | EDGAR |
| 2022-10-07 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-03-24 | OTLK | Grant (A) | — | $0 | EDGAR |